Excitation of Rat Colonic Afferent Fibres by 5-HT(3) Receptors

Overview

Journal J Physiol

Specialty Physiology

Date 2002 Nov 2

PMID 12411529

Citations 36

Authors

Gareth A Hicks

Jonathan R Coldwell

Marcus Schindler

Philip A Bland Ward

David Jenkins

Penny A Lynn

Patrick P A Humphrey

L Ashley Blackshaw

Affiliations

Soon will be listed here.

Abstract

The gastrointestinal tract contains most of the body's 5-hydroxytryptamine (5-HT) and releases large amounts after meals or exposure to toxins. Increased 5-HT release occurs in patients with irritable bowel syndrome (IBS) and their peak plasma 5-HT levels correlate with pain episodes. 5-HT(3) receptor antagonists reduce symptoms of IBS clinically, but their site of action is unclear and the potential for other therapeutic targets is unexplored. Here we investigated effects of 5-HT on sensory afferents from the colon and the expression of 5-HT(3) receptors on their cell bodies in the dorsal root ganglia (DRG). Distal colon, inferior mesenteric ganglion and the lumbar splanchnic nerve bundle (LSN) were placed in a specialized organ bath. Eighty-six single fibres were recorded from the LSN. Three classes of primary afferents were found: 70 high-threshold serosal afferents, four low-threshold muscular afferents and 12 mucosal afferents. Afferent cell bodies were retrogradely labelled from the distal colon to the lumbar DRG, where they were processed for 5-HT(3) receptor-like immunoreactivity. Fifty-six percent of colonic afferents responded to 5-HT (between 10(-6) and 10(-3) M) and 30 % responded to the selective 5-HT(3) agonist, 2-methyl-5-HT (between 10(-6) and 10(-2) M). Responses to 2-methyl-5-HT were blocked by the 5-HT(3) receptor antagonist alosetron (2 x 10(-7) M), whereas responses to 5-HT were only partly inhibited. Twenty-six percent of L1 DRG cell bodies retrogradely labelled from the colon displayed 5-HT(3) receptor-like immunoreactivity. We conclude that colonic sensory neurones expressing 5-HT(3) receptors also functionally express the receptors at their peripheral endings. Our data reveal actions of 5-HT on colonic afferent endings via both 5-HT(3) and non-5-HT(3) receptors.

Citing Articles

Functional and Structural Investigation of Myenteric Neurons in the Human Colon.

Elfers K, Sehnert A, Wagner A, Zwirner U, Linge H, Kulik U Gastro Hep Adv. 2025; 4(1):100537.

PMID: 39790245 PMC: 11714724. DOI: 10.1016/j.gastha.2024.08.016.

Gut enterochromaffin cells drive visceral pain and anxiety.

Bayrer J, Castro J, Venkataraman A, Touhara K, Rossen N, Morrie R Nature. 2023; 616(7955):137-142.

PMID: 36949192 PMC: 10827380. DOI: 10.1038/s41586-023-05829-8.

The enteric nervous system.

Sharkey K, Mawe G Physiol Rev. 2022; 103(2):1487-1564.

PMID: 36521049 PMC: 9970663. DOI: 10.1152/physrev.00018.2022.

5-HT3 Receptors in Rat Dorsal Root Ganglion Neurons: Ca Entry and Modulation of Neurotransmitter Release.

Martinello K, Sucapane A, Fucile S Life (Basel). 2022; 12(8).

PMID: 36013357 PMC: 9409985. DOI: 10.3390/life12081178.

Management Options for Irritable Bowel Syndrome.

Camilleri M Mayo Clin Proc. 2018; 93(12):1858-1872.

PMID: 30522596 PMC: 6314474. DOI: 10.1016/j.mayocp.2018.04.032.

References

Furness J, Koopmans H, Robbins H, Lin H . Identification of intestinofugal neurons projecting to the coeliac and superior mesenteric ganglia in the rat. Auton Neurosci. 2000; 83(1-2):81-5. DOI: 10.1016/S0165-1838(00)00159-4. View

Blackshaw L, Grundy D . Effects of 5-hydroxytryptamine on discharge of vagal mucosal afferent fibres from the upper gastrointestinal tract of the ferret. J Auton Nerv Syst. 1993; 45(1):41-50. DOI: 10.1016/0165-1838(93)90360-7. View

Zeitz K, Guy N, Malmberg A, Dirajlal S, Martin W, Sun L . The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. J Neurosci. 2002; 22(3):1010-9. PMC: 6758503. View

Paintal A . The response of gastric stretch receptors and certain other abdominal and thoracic vagal receptors to some drugs. J Physiol. 1954; 126(2):271-85. PMC: 1365717. DOI: 10.1113/jphysiol.1954.sp005208. View

Luckensmeyer G, Keast J . Distribution and morphological characterization of viscerofugal projections from the large intestine to the inferior mesenteric and pelvic ganglia of the male rat. Neuroscience. 1995; 66(3):663-71. DOI: 10.1016/0306-4522(94)00599-z. View

Chen J, Vasko M, Wu X, Staeva T, Baez M, Zgombick J . Multiple subtypes of serotonin receptors are expressed in rat sensory neurons in culture. J Pharmacol Exp Ther. 1998; 287(3):1119-27. View

Spiller R, Jenkins D, Thornley J, Hebden J, Wright T, Skinner M . Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000; 47(6):804-11. PMC: 1728147. DOI: 10.1136/gut.47.6.804. View

Kirchgessner A, Tamir H, Gershon M . Identification and stimulation by serotonin of intrinsic sensory neurons of the submucosal plexus of the guinea pig gut: activity-induced expression of Fos immunoreactivity. J Neurosci. 1992; 12(1):235-48. PMC: 6575678. View

Lynn P, Blackshaw L . In vitro recordings of afferent fibres with receptive fields in the serosa, muscle and mucosa of rat colon. J Physiol. 1999; 518(Pt 1):271-82. PMC: 2269405. DOI: 10.1111/j.1469-7793.1999.0271r.x. View

10.

BLUMBERG H, Haupt P, Janig W, Kohler W . Encoding of visceral noxious stimuli in the discharge patterns of visceral afferent fibres from the colon. Pflugers Arch. 1983; 398(1):33-40. DOI: 10.1007/BF00584710. View

11.

Zhu J, Zhu X, Owyang C, Li Y . Intestinal serotonin acts as a paracrine substance to mediate vagal signal transmission evoked by luminal factors in the rat. J Physiol. 2001; 530(Pt 3):431-42. PMC: 2278417. DOI: 10.1111/j.1469-7793.2001.0431k.x. View

12.

Kozlowski C, Green A, Grundy D, Boissonade F, Bountra C . The 5-HT(3) receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat. Gut. 2000; 46(4):474-80. PMC: 1727898. DOI: 10.1136/gut.46.4.474. View

13.

Camilleri M, Northcutt A, Kong S, Dukes G, McSorley D, Mangel A . Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet. 2000; 355(9209):1035-40. DOI: 10.1016/S0140-6736(00)02033-X. View

14.

Bearcroft C, Perrett D, Farthing M . Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut. 1998; 42(1):42-6. PMC: 1726971. DOI: 10.1136/gut.42.1.42. View

15.

Zhai J, Gershon M, Walsh J, Wong H, Kirchgessner A . Inward currents in neurons from newborn guinea pig intestine: mediation by 5-hydroxytryptamine type 3 receptors. J Pharmacol Exp Ther. 1999; 291(1):374-82. View

16.

Bertrand P, Kunze W, Furness J, Bornstein J . The terminals of myenteric intrinsic primary afferent neurons of the guinea-pig ileum are excited by 5-hydroxytryptamine acting at 5-hydroxytryptamine-3 receptors. Neuroscience. 2000; 101(2):459-69. DOI: 10.1016/s0306-4522(00)00363-8. View

17.

Fu L, Longhurst J . Role of 5-HT3 receptors in activation of abdominal sympathetic C fibre afferents during ischaemia in cats. J Physiol. 1998; 509 ( Pt 3):729-40. PMC: 2231001. DOI: 10.1111/j.1469-7793.1998.729bm.x. View

18.

Blackshaw L, Grundy D . Effects of 5-hydroxytryptamine (5-HT) on the discharge of vagal mechanoreceptors and motility in the upper gastrointestinal tract of the ferret. J Auton Nerv Syst. 1993; 45(1):51-9. DOI: 10.1016/0165-1838(93)90361-w. View

19.

Camilleri M . Management of the irritable bowel syndrome. Gastroenterology. 2001; 120(3):652-68. DOI: 10.1053/gast.2001.21908. View

20.

Lembo T, Munakata J, Mertz H, Niazi N, Kodner A, Nikas V . Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome. Gastroenterology. 1994; 107(6):1686-96. DOI: 10.1016/0016-5085(94)90809-5. View